CGM Studies Oct 6, 2018 Share Facebook Twitter LinkedIn In your experience, what have most studies about CGM demonstrated? HbA1c is lower in CGM users regardless of age or type of insulin delivery. Patients using MDI + CGM have greater reductions in HbA1c than those using CSII + CGM. Reductions in glycemic variability and time spent in hypoglycemia are not significantly different between SAP and MDI/RT-CGM therapy groups. All of the above View Results Loading ...